Skip to main content

Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data shows

Pfizer said it will submit an application to the Food and Drug Administration for the RSV vaccine's approval by the end of 2022.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.